Mark Salji

4PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsElectrometallurgy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 18, 2022
Phase II proof-of-concept study of atorvastatin in castration-resistant prostate cancer.

Linda K Rushworth, Carolyn Loveridge, Mark Salji

|Jan 11, 2022
THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.

Arnaud Blomme, Coralie Peter, Ernest Mui

|May 14, 2021
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer.

Rafael S Martinez, Mark J Salji, Linda Rushworth

|Dec 14, 2018
Bright insights into palladium-triggered local chemotherapy.

Thomas L Bray, Mark Salji, Alessandro Brombin

Pageof 1